AbCellera Biologics Inc.

ABCL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001703057

SEC filings (opens in a new tab)

In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding AbCellera Biologics Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of ABCL: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Of which not filed for Q4 2023	Q4 2023	Change
Holders	138	2	143	+7
Shares	120.0M	37.0K	119.2M	−810.2K (−0.7%)
Value	$551.8M	$170.0K	$681.1M	+$129.5M (+23.5%)

2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held AbCellera Biologics Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to ABCL in Q4 2023
Institution	Shares	Value	% of portfolio
FIL Ltd	1,875,872	$10.7M	0.01%
ExodusPoint Capital Management, LP	133,654	$763.0K	0.01%
TrueMark Investments, LLC	96,853	$553.0K	0.55%
Northern Trust Corp	56,477	$322.5K	0.00%
Alliancebernstein L.P.	39,472	$225.4K	0.00%
MQS Management LLC	35,223	$201.1K	0.11%
Lantern Wealth Advisors, LLC	22,550	$128.8K	0.10%
JGP Global Gestao de Recursos Ltda.	17,417	$99.5K	0.10%
Pathstone Holdings, LLC	16,714	$95.4K	0.00%
Balyasny Asset Management LLC	14,853	$84.8K	0.00%
JustInvest LLC	14,259	$81.4K	0.00%
Creative Planning	13,720	$78.3K	0.00%
Vanguard Group Inc	13,112	$74.9K	0.00%
Raymond James Financial Services Advisors, Inc.	10,935	$62.4K	0.00%
Farther Finance Advisors, LLC	10,012	$57.2K	0.00%
AA Financial Advisors, LLC	10,000	$57.1K	0.04%
UBS Group AG	2,500	$14.3K	0.00%
Baystate Wealth Management LLC	500	$2.85K	0.00%
Principal Securities, Inc.	352	$2.01K	0.00%
Householder Group Estate & Retirement Specialist, LLC	500	$2.00K	0.00%
CVA Family Office, LLC	230	$1.31K	0.00%
Parkside Financial Bank & Trust	200	$1.14K	0.00%
LM Advisors LLC	200	$1.14K	0.00%
Financial Synergies Wealth Advisors, Inc.	89	$902	0.00%
Northwestern Mutual Wealth Management Co	150	$857	0.00%
GAMMA Investing LLC	54	$276	0.00%

Sold out (19)

Institutions that held AbCellera Biologics Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of ABCL in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Alyeska Investment Group, L.P.	501,355	$2.31M
Schonfeld Strategic Advisors LLC	358,400	$1.65M
Trexquant Investment LP	272,158	$1.25M
Ensign Peak Advisors, Inc	166,000	$763.6K
XTX Topco Ltd	44,331	$203.9K
Bridgefront Capital, LLC	35,905	$165.2K
Quent Capital, LLC	27,860	$128.2K
Axq Capital, LP	27,000	$124.2K
Qube Research & Technologies Ltd	26,967	$124.0K
LMR Partners LLP	25,236	$116.1K
Amundi	26,567	$113.2K
Tudor Investment Corp Et Al	20,105	$92.5K
Janney Montgomery Scott LLC	19,064	$88.0K
Commonwealth Equity Services, LLC	12,019	$55.0K
Vontobel Holding Ltd.	10,003	$46.0K
Good Life Advisors, LLC	10,000	$46.0K
Allworth Financial LP	335	$1.54K
CGC Financial Services, LLC	40	$184
Coppell Advisory Solutions LLC	252	–

Not filed for Q4 2023 yet (2)

Institutions that held AbCellera Biologics Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ABCL in Q3 2023 that haven't filed for Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Quantamental Technologies LLC	19,570	$90.0K
Pathstone Family Office, LLC	17,390	$80.0K